Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast CancerDOWNEY, Leona; LIVINGSTON, Robert B; KOEHIER, Maria et al.Clinical cancer research (Print). 2010, Vol 16, Num 4, pp 1281-1288, issn 1078-0432, 8 p.Article

External Beam Irradiation and the Combination of Cisplatin and Carmustine Followed by Carmustine Alone for the Treatment of High-grade Glioma : A Phase 2 Southwest Oncology Group TrialBLUMENTHAL, Deborah T; RANKIN, Cathryn; PETERSDORF, Stephen H et al.Cancer. 2008, Vol 113, Num 3, pp 559-565, issn 0008-543X, 7 p.Article

Adjuvant vinorelbine and cisplatin in elderly patients : National cancer institute of Canada and intergroup study JBR. 10PEPE, Carmela; HASAN, Baktiar; WINTON, Timothy L et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1553-1561, issn 0732-183X, 9 p.Article

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer : Final analysis from INT-0137 (s9313)LINDEN, Hannah M; HASKELL, Charles M; MARTINO, Silvana et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 656-661, issn 0732-183X, 6 p.Article

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer : Updated findings from NCIC CTG MA.17GOSS, Paul E; INGLE, James N; LIVINGSTON, Robert B et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 17, pp 1262-1271, issn 0027-8874, 10 p.Article

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a southwest oncology group trialKELLY, Karen; CROWLEY, John; ISRAEL, Valerie K et al.Journal of clinical oncology. 2001, Vol 19, Num 13, pp 3210-3218, issn 0732-183XArticle

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)SUCHESTON, Lara E; HUA ZHAO; CIUPAK, Gregory L et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 993-1002, issn 0167-6806, 10 p.Article

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)SLOVAK, Marilyn L; BEDELL, Victoria; STOCK, Wendy et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 391-398, issn 0167-6806, 8 p.Article

Gene Polymorphisms in Cyclophosphamide Metabolism Pathway, Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast CancerSONG YAO; BARLOW, William E; RAVDIN, Peter M et al.Clinical cancer research (Print). 2010, Vol 16, Num 24, pp 6169-6176, issn 1078-0432, 8 p.Article

Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical TrialCHOI, Ji-Yeob; BARLOW, William E; RAVDIN, Peter M et al.Clinical cancer research (Print). 2009, Vol 15, Num 16, pp 5258-5266, issn 1078-0432, 9 p.Article

Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. DiscussionKELLER, Steven M; VANGEL, Mark G; WALSH, Garrett L et al.Journal of thoracic and cardiovascular surgery. 2004, Vol 128, Num 1, pp 130-137, issn 0022-5223, 8 p.Conference Paper

Ten-year follow-up of Southwest Oncology Group 8269 : a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancerTHOMAS, Charles R; GIROUX, Dorothy J; GANDARA, David R et al.Lung cancer. 2001, Vol 33, Num 2-3, pp 213-219, issn 0169-5002Article

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancerKELLER, Steven M; ADAK, Sudeshna; WAGNER, Henry et al.The New England journal of medicine. 2000, Vol 343, Num 17, pp 1217-1222, issn 0028-4793Article

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast CancerSWAIN, Sandra M; JEONG, Jong-Hyeon; RASTOGI, Priya et al.The New England journal of medicine. 2010, Vol 362, Num 22, pp 2053-2065, issn 0028-4793, 13 p.Article

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialALBAIN, Kathy S; SUZANNE SWANN, R; FY, Willard A et al.Lancet (British edition). 2009, Vol 374, Num 9687, pp 379-386, issn 0140-6736, 8 p.Article

Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer : Results From a Randomized Trial, JBR.10BEZJAK, Andrea; LEE, Christopher W; SHEPHERD, Frances A et al.Journal of clinical oncology. 2008, Vol 26, Num 31, pp 5052-5059, issn 0732-183X, 8 p.Article

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography : Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast CancerDUNNWALD, Lisa K; GRALOW, Julie R; SCHUBERT, Erin K et al.Journal of clinical oncology. 2008, Vol 26, Num 27, pp 4449-4457, issn 0732-183X, 9 p.Article

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trialINGLE, James N; DONGSHENG TU; LIVINGSTON, Robert B et al.Breast cancer research and treatment. 2006, Vol 99, Num 3, pp 295-300, issn 0167-6806, 6 p.Article

p27^Kip1 and cyclin e expression and breast cancer survival after treatment with adjuvant chemotherapyPORTER, Peggy L; BARLOW, William E; ALBAIN, Kathy S et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 23, pp 1723-1731, issn 0027-8874, 9 p.Article

Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: A retrospective review by the Southwest Oncology GroupGASPAR, Laurie E; CHANSKY, Kari; ALBAIN, Kathy S et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 2955-2961, issn 0732-183X, 7 p.Conference Paper

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapyMANKOFF, David A; DUNNWALD, Lisa K; GRALOW, Julie R et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 11, pp 1806-1814, issn 0161-5505, 9 p.Article

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer : A phase II trial of the southwest oncology groupKELLY, Karen; LOVATO, Laura; BUNN, Paul A et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2325-2329, issn 1078-0432Article

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancerBELLON, Jennifer R; LINDSLEY, Karen L; ELLIS, Georgiana K et al.International journal of radiation oncology, biology, physics. 2000, Vol 48, Num 2, pp 393-397, issn 0360-3016Conference Paper

Combination Anastrozole and Fulvestrant in Metastatic Breast CancerMEHTA, Rita S; BARLOW, William E; HORTOBAGYI, Gabriel N et al.The New England journal of medicine. 2012, Vol 367, Num 5, pp 435-444, issn 0028-4793, 10 p.Article